Wagner on the Investigation of Nab-Sirolimus in Advanced Malignant PEComa

Dr Wagner discusses unmet needs for patients with PEComa, ongoing research to address these gaps, and findings from the AMPECT trial.

Related Keywords

Boston ,Massachusetts ,United States ,Caroline Seymour ,Andrewj Wagner ,Dana Faber Cancer Institute ,Harvard Medical School ,Facebook ,Linkedin ,Twitter ,Live On Air ,Ambulatory Oncology ,Onclive On Air ,Apple Podcasts ,Google Podcasts ,Amazon Music ,D ,Phd ,Patients With Pecoma ,Ampect Trial ,